Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts - Test2 - elhamkhani - TriplyDB

Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts

Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts

http://www.wikidata.org/entity/Q24594810

about

Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents How complete are E-codes in commercial plan claims databases?Antidepressants and Suicide Risk: A Comprehensive Overview Analysis of pediatric clinical drug trials for neuropsychiatric conditions Identification of hospitalizations for intentional self-harm when E-codes are incompletely recorded.A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples.Antidepressant agents and suicide death among US Department of Veterans Affairs patients in depression treatment.Suicide-related events in young people following prescription of SSRIs and other antidepressants: a self-controlled case series analysis.Lower anxiogenic effects of serotonin agonists are associated with lower activation of amygdala and lateral orbital cortex in adolescent male rats Antidepressants and suicide attempts in children Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.Delays in psychiatric drug development in Japan.Paroxetine for the treatment of depression: a critical update.Metabolic and toxicological considerations for obsessive-compulsive disorder drug therapy.Comparative efficacies of fluoxetine and paroxetine in major depression across varying acute-phase treatment periods: a meta-analysis.Do antidepressants make children and adolescents suicidal?A Review of Pharmacological Treatments for Depression in Alzheimer's Disease.Extent and risks of antidepressant off-label use in children and adolescents in Germany between 2004 and 2011.Conducting Privacy-Preserving Multivariable Propensity Score Analysis When Patient Covariate Information Is Stored in Separate Locations.Comparative risk of self-harm hospitalization amongst depressive disorder patients using different antidepressants: a population-based cohort study in Taiwan.Drug lag for cardiovascular drug approvals in India compared with the US and EU approvals.Collaborative-controlled LASSO for constructing propensity score-based estimators in high-dimensional data.Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system.Re: Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records.

P2860

Q24193517-91AC2585-17DA-4217-A27F-4A497E7827DA Q28390387-7E5B7BB7-A5C1-4D65-ADC3-BB0C8466CE0F Q33664712-D50957FF-42EE-48BB-A6E2-D9A64A3D9ACB Q33819758-EE9480B7-A480-4226-8C70-E9A549B8CBF8 Q34351141-2A9B0FA1-9DC1-4CFD-B8C7-AF168F8C0A41 Q34530447-2E28CDB0-1DEA-44B7-8217-1FE14ECFAB53 Q35090255-5805462F-765B-46A1-BB34-82CC4BA8B160 Q35133118-7013B84F-69F9-4C86-84E2-AAB811019A72 Q36454588-D481A6AD-3762-4848-9BEA-DD1478704A36 Q37190246-6C3A7EFC-5C4E-41DD-A4A8-851E0B0D0D9D Q37266988-B723E3BD-FB10-4069-BD1A-20FD536A38BD Q37522908-5B5E0023-8000-4B02-910B-256D5D89255C Q37625703-2B640F0D-B041-44DC-9E74-2CA39B3A8556 Q37948093-10AAFB54-270E-4ACD-946B-34509FDA6065 Q37977501-D88236CC-0845-4C48-ADC4-643C34F81773 Q38092129-42A042FB-7269-489B-8F9A-B433D4305311 Q38154837-B338AA57-D6EE-47B4-B5B3-6244978D99A9 Q38221283-ED5538B7-B7F5-4B52-9A2A-E1C32D4AAE16 Q38592128-8AF565F4-7766-4521-979C-CD149AEE2721 Q38608635-03155252-7CD4-45D2-A5F2-741621C7A679 Q38842063-76901AB5-7A1A-41C3-A82F-E4DBEA0DD727 Q39360265-2ADD90F1-E566-4BA6-BF48-9CB38F14BE5D Q41889038-A2DE69A0-6F4D-4525-8762-277B5730681A Q46214600-EE93767C-AF37-4AC9-8896-1015FD8A6450 Q51440489-9DD41711-64B8-4A1C-B815-AAC9B6766FD2 Q51528325-3880EB2C-A19D-4E9E-B38C-85ED5F7675DE

P2860

Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts

http://www.wikidata.org/entity/Q24594810

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Comparative safety of antidepr ...... scents regarding suicidal acts

@ast

Comparative safety of antidepr ...... scents regarding suicidal acts

@en

Comparative safety of antidepr ...... scents regarding suicidal acts

@nl

type

label

Comparative safety of antidepr ...... scents regarding suicidal acts

@ast

Comparative safety of antidepr ...... scents regarding suicidal acts

@en

Comparative safety of antidepr ...... scents regarding suicidal acts

@nl

prefLabel

Comparative safety of antidepr ...... scents regarding suicidal acts

@ast

Comparative safety of antidepr ...... scents regarding suicidal acts

@en

Comparative safety of antidepr ...... scents regarding suicidal acts

@nl

P1433

Q24594810-B3E67A6A-1A6C-454E-9945-4CC6D0E4333D

P1476

Q24594810-92D014C3-AB43-4A6C-9A7F-ECDB396EEBB7

P2093

Q24594810-1130D88D-C364-4079-B0EC-405F738B1D21

Q24594810-6A99F954-8472-4D9D-9711-E0E545F6240A

Q24594810-76E6A921-5FE7-473C-85C5-405FC7B144EA

Q24594810-8E578638-9F44-4323-B8CB-BEFD834B38C5

Q24594810-913B09CA-5ADA-4459-A5C3-633B69563E4C

Q24594810-9469C3D7-6F0A-4AD7-AFFD-B0CC5574BC21

Q24594810-A4422B55-0DE3-4565-83A4-36AF2F57E46C

Q24594810-E43A6B82-B480-44D7-BF51-CB8F79DD9FF8

P2860

Q24594810-0587EB92-1076-4BA1-BDF1-6538BBCC6A33

Q24594810-34E405E6-EF8A-4120-8A2E-3EA128F3720A

Q24594810-4B60A0DA-D2CC-4F6C-A936-FCB1548C2B21

Q24594810-4C632E18-4CAD-490B-8124-6E1CD1D7881A

Q24594810-4D6C229C-1366-4DE7-8833-0E6866D1DEC4

Q24594810-6E1F66AF-043C-440A-8FBA-5DE5B57FB63B

Q24594810-801D01F8-FC5D-40AC-B62B-BCBA7CE0BB16

Q24594810-817C28CE-4ADD-4854-897D-957FF407ADDC

Q24594810-855F7DD6-0686-41B1-9823-7391AA9D67BB

Q24594810-86F0B879-8BC0-4C87-8453-4CBA5CBCA364

P304

Q24594810-2EB61216-E717-45B4-99F1-4FA3FC59F502

P31

Q24594810-F536E89E-346D-4E0B-848D-C4057CA43F9B

P356

Q24594810-76073C0B-2102-4341-ABA6-A4EAFC8093EA

P407

Q24594810-5E008D90-F849-4F18-A633-91F444A4E257

P433

Q24594810-14D4E626-7151-49FD-94AC-0ADD41EE2748

P478

Q24594810-E6DAF031-D362-46BD-974E-4E4296154863

P577

Q24594810-C0C57EBB-4F30-4867-BC3E-427DB557E7DB

P5875

Q24594810-C9632588-5EC9-4C7F-82A5-8786BA478DF5

P698

Q24594810-16161055-38B0-416E-BBDD-C3C608E44223

P921

Q24594810-6C759E8D-8B62-4FE0-BEFE-A19495FC3FB3

Q24594810-8931D8C0-6DB9-4E38-8A7E-B5B99D14B99A

Q24594810-AAD25DA1-E745-466D-8C95-0DF020408977

Q24594810-D6F6F71A-9943-4B1B-9CF1-0F1F98473A05

P932

Q24594810-29BBBE70-9C0B-4D5A-8C12-1FD0D69953FA

P356

P1433

P1476

Comparative safety of antidepr ...... scents regarding suicidal acts

@en

P2093

Amanda R Patrick

http://www.w3.org/2001/XMLSchema#string

Colin R Dormuth

http://www.w3.org/2001/XMLSchema#string

Daniel H Solomon

http://www.w3.org/2001/XMLSchema#string

Jennifer C Lee

http://www.w3.org/2001/XMLSchema#string

Jyotsna Mehta

http://www.w3.org/2001/XMLSchema#string

Matt Miller

http://www.w3.org/2001/XMLSchema#string

Philip S Wang

http://www.w3.org/2001/XMLSchema#string

Sebastian Schneeweiss

http://www.w3.org/2001/XMLSchema#string

P2860

Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study.

Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study.

The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials.

Antidepressants and the risk of suicidal behaviors.

Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort.

Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication.

A review of uses of health care utilization databases for epidemiologic research on therapeutics.

P304

876-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.2009-2317

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43130828

http://www.w3.org/2001/XMLSchema#string

P698

20385637

http://www.w3.org/2001/XMLSchema#string

P921

suicide prevention

P932

2884182

http://www.w3.org/2001/XMLSchema#string